Polen Capital Management Llc released its “Polen Focus Growth Strategy” Q4 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, the Polen Focus Growth strategy delivered a -1.37% gross return, underperforming the Russell 1000 Growth Index (+1.12%) and the S&P 500 (+2.66%), as concentrated mega‑cap leadership and AI valuation concerns drove market volatility. The fund faced headwinds from market rotation and valuation pressures but remained disciplined in its investment approach, focusing on companies with durable competitive advantages and diversified earnings. Portfolio adjustments were made to optimize long-term growth potential, and despite short-term challenges, the fund maintains a constructive medium- to long-term outlook, expecting broader market opportunities beyond narrow leadership trends to support balanced returns for investors. In addition, please check the fund’s top five holdings to know its best picks in 2025.
In its fourth-quarter 2025 investor letter, Polen Capital Management highlighted stocks like Intuitive Surgical, Inc. (NASDAQ:ISRG). Intuitive Surgical, Inc. (NASDAQ:ISRG) is a medical technology leader best known for its robotic-assisted surgery systems, with growth supported by rising procedure volumes and long-term adoption of minimally invasive surgery. The one-month return of Intuitive Surgical, Inc. (NASDAQ:ISRG) was -7.30% while its shares traded between $425.00 and $609.08 over the last 52 weeks. On January 27, 2026, Intuitive Surgical, Inc. (NASDAQ:ISRG) stock closed at approximately $525.04 per share, with a market capitalization of about $186.12 billion.
Polen Capital Management Llc stated the following regarding Intuitive Surgical, Inc. (NASDAQ:ISRG) in its Polen Focus Growth Strategy’s Q4 2025 investor letter:
“In Q4 2025, we initiated a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) and sold our positions in Netflix and Workday. We initiated a 2.25% position in Intuitive Surgical who maintain a de facto monopoly in soft tissue robotic surgery globally. They have become the standard of care in many surgical modalities while there are many more open and laparoscopic surgeries that can be converted to robotic over time. The barriers to entering their market are large based on decades of proven efficacy and safety, as well as the fact most surgeons are trained on the company’s Da Vinci robots either in medical school or on the job, and they continue to innovate and distance themselves from potential entrants. The company recently fully launched its next generation platform that should lead to accelerating procedure growth and revenue growth for years. Current results show this acceleration, and we see clear business momentum and a reasonable valuation considering this is an accelerating monopoly.”
Copyright: nimon / 123RF Stock Photo
Intuitive Surgical, Inc. (NASDAQ:ISRG) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 99 hedge fund portfolios held Intuitive Surgical, Inc. (NASDAQ:ISRG) at the end of the third quarter, which was 107 in the previous quarter. While we acknowledge the risk and potential of Intuitive Surgical, Inc. (NASDAQ:ISRG) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Intuitive Surgical, Inc. (NASDAQ:ISRG) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Intuitive Surgical, Inc. (NASDAQ:ISRG) and shared the list of stocks that were discussed by Jim Cramer. In addition, please check out our hedge fund investor letters Q4 2025 page for more investor letters from hedge funds and other leading investors.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. This article is originally published at Insider Monkey.
